Neoadjuvant and adjuvant strategies for pancreatic cancer.

Neoadjuvant and adjuvant strategies for pancreatic cancer.

Item
http://www.wikidata.org/entity/Q36971259
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla.Survival in population-based pancreatic cancer patients: San Francisco Bay area, 1995-1999.Genomic expression profiling and bioinformatics analysis of pancreatic cancerFGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancerCentralization of services and reduction of adverse events in pancreatic cancer surgery.Membrane drug transporters and chemoresistance in human pancreatic carcinoma.Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer.Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling
P2860

Neoadjuvant and adjuvant strategies for pancreatic cancer.

Item
http://www.wikidata.org/entity/Q36971259
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neoadjuvant and adjuvant strategies for pancreatic cancer.
@en
type
label
Neoadjuvant and adjuvant strategies for pancreatic cancer.
@en
prefLabel
Neoadjuvant and adjuvant strategies for pancreatic cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Neoadjuvant and adjuvant strategies for pancreatic cancer.
@en
P2093
P304
P31
P356
10.1016/J.EJSO.2007.07.204
P433
P478
P577
P698